Use of IGIV in the treatment of atopic dermatitis, urticaria, scleromyxedema, pyoderma gangrenosum, psoriasis, and pretibial myxedema

International Immunopharmacology
Stephen Jolles, Jenny Hughes

Abstract

There has been a rapid expansion in the use of IGIV for an ever-growing number of conditions. It is a product with an excellent safety record without the side effects of steroids or other immunosuppressive agents. There have been numerous recent advances in our understanding of the mechanisms of action of IGIV in many of the conditions for which it is being used, but there is still much to be learned. IGIV has had a major impact in neurology, haematology, immunology, rheumatology and dermatology. The limitations for IGIV are cost of the preparation itself and the logistical problems associated with its administration. Here we describe the published evidence for the use of high-dose IGIV in the dermatological conditions atopic dermatitis, urticaria, scleromyxedema, pyoderma gangrenosum, psoriasis and pretibial myxedema. These conditions have an emerging evidence base for hdIGIV which is relatively small consisting mainly of case reports and small case series. The outcomes in a number of these conditions appear encouraging, but as the reports are likely to reflect a bias for positive results, one must be cautious about drawing firm conclusions.

References

Jan 1, 1994·Thyroid : Official Journal of the American Thyroid Association·A AntonelliL Baschieri
Jan 1, 1995·Journal of the American Academy of Dermatology·A K GuptaD N Sauder
Jun 9, 1994·The New England Journal of Medicine·F E Simons, K J Simons
Apr 1, 1994·Archives of Disease in Childhood·H Kimata
Oct 1, 1993·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·S A Misbah, H M Chapel
Feb 1, 1997·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·S J WeissV R Bonagura
Feb 1, 1997·The British Journal of Dermatology·B F O'DonnellM W Greaves
Jul 1, 1997·Journal of Neurology, Neurosurgery, and Psychiatry·W A SewellH M Chapel
Feb 5, 1998·Archives of Dermatology·S JollesS Whittaker
Apr 16, 1998·The British Journal of Dermatology·B F O'DonnellM W Greaves
Apr 29, 1998·BMJ : British Medical Journal·S Jolles, H Hill
Jun 26, 1998·The British Journal of Dermatology·F Humphreys, J A Hunter
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·D A YoungT J Smith
Sep 2, 1998·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·M WakimE R Stiehm
Nov 12, 1998·Journal of the American Academy of Dermatology·T DirschkaP Altmeyer
Apr 2, 1999·Journal of Korean Medical Science·G Noh, K Y Lee
Feb 17, 2000·Journal of the Neurological Sciences·F T RottaR T Shebert
Feb 7, 2001·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·J L HuangK H Hsieh
Aug 22, 2000·The British Journal of Dermatology·C E GrattanM W Greaves
Aug 23, 2000·Acta Dermato-venereologica·M KroissW Stolz
Jan 10, 2002·Annals of the Rheumatic Diseases·A RighiM Matucci Cerinic
Aug 13, 2002·The Journal of Dermatological Treatment·J H HagmanS Chimenti
Sep 5, 2002·The British Journal of Dermatology·V GurminH L C Beynon
Dec 4, 2002·Immunology·W A C Sewell, S Jolles
Feb 13, 2003·International Journal of Dermatology·John J Pomann, Earl J Rudner
Mar 15, 2003·Journal of the American Academy of Dermatology·Christopher M DobsonSusan Evans
Mar 26, 2003·Clinical and Experimental Dermatology·P TerheydenE-B Bröcker
Apr 1, 1958·A.M.A. Archives of Dermatology·D BLOOMM DANNENBERG
Nov 18, 2003·The British Journal of Dermatology·G DawnW S Douglas
Apr 30, 2004·Clinical and Experimental Dermatology·A KarimM M Black
Jul 10, 2004·Journal of the American Academy of Dermatology·Julia C SansburyGiampiero Girolomoni
Jul 29, 2004·Journal of the American Academy of Dermatology·Keren B HornJoan Guitart

❮ Previous
Next ❯

Citations

Jun 27, 2009·Clinical Reviews in Allergy & Immunology·Norito IshiiRalf J Ludwig
Jul 11, 2009·Clinical Reviews in Allergy & Immunology·Shaye KivityYehuda Shoenfeld
Apr 25, 2014·Gastroenterology Report·Xian-Rui Wu, Bo Shen
Mar 29, 2007·Proceedings of the National Academy of Sciences of the United States of America·Roberto RocchiPatrizio Caturegli
Oct 7, 2014·Indian Journal of Dermatology·Virendra N SehgalAnanta Khurana
Jun 19, 2012·The Medical Clinics of North America·Robyn S FallenHermenio C Lima
Oct 30, 2007·Journal of Cataract and Refractive Surgery·Pierre FourniéJean-Louis Arné
Jul 25, 2009·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Alexander EnkDetlef Zillikens
Oct 6, 2007·The British Journal of Dermatology·D L CumminsJ H Meyerle
Oct 4, 2007·Annals of the New York Academy of Sciences·Tariq El-Shanawany, Stephen Jolles
Feb 23, 2007·The British Journal of Dermatology·A C Kerr, J Ferguson
Apr 21, 2012·Journal of Cutaneous Pathology·Kirsten E FlemingNoreen M Walsh
Nov 27, 2014·Pediatric Dermatology·Loretta FiorilloImam Hemmati
Feb 6, 2007·International Immunopharmacology·Elisabeth MaierHans Peter Schwarz
Dec 31, 2016·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Alexander EnkDetlef Zillikens
Feb 19, 2017·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Alexander EnkDetlef Zillikens
Jan 20, 2007·Journal of Cutaneous Medicine and Surgery·P Régine MydlarskiNeil H Shear
Mar 12, 2019·Thyroid : Official Journal of the American Thyroid Association·Anupam KotwalMarius N Stan
Oct 21, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·A H EnkD Zillikens
May 22, 2020·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·Eva HadaschikAlexander Enk
Feb 9, 2011·Clinical Neuropharmacology·Irina ElovaaraBirgit Reipert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Basophils

Basophils are myeloid cells with a high affinity IgE receptor and is involved in inflammatory responses during allergy. Discover the latest research on Basophils here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.